Shaojian Lin Selected Research

Thyroid Neoplasms (Thyroid Cancer)

1/2022	METTL3-Induced miR-222-3p Upregulation Inhibits STK4 and Promotes the Malignant Behaviors of Thyroid Carcinoma Cells.
1/2022	Circular RNA_0057209 Acts as ceRNA to Inhibit Thyroid Cancer Progression by Promoting the STK4-Mediated Hippo Pathway via Sponging MicroRNA-183.
1/2020	Long non-coding RNA TNRC6C-AS1 promotes methylation of STK4 to inhibit thyroid carcinoma cell apoptosis and autophagy via Hippo signalling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaojian Lin Research Topics

Disease

11	Neoplasms (Cancer) 04/2022 - 01/2014
6	Papillary Thyroid Cancer 04/2022 - 10/2014
4	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2017
3	Thyroid Neoplasms (Thyroid Cancer) 01/2022 - 01/2020
3	Pituitary Neoplasms (Pituitary Adenoma) 01/2021 - 01/2014
3	Prolactinoma (Prolactinomas) 01/2020 - 01/2014
2	Carcinogenesis 01/2021 - 02/2019
1	Pituitary ACTH Hypersecretion 01/2022
1	Obesity 01/2022
1	Fibrosis (Cirrhosis) 12/2021
1	Leukemia 12/2021
1	Lentivirus Infections 05/2021
1	Diabetes Mellitus 04/2021
1	Trigeminal Neuralgia (Tic Douloureux) 04/2021
1	Hypoxia (Hypoxemia) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Glioma (Gliomas) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Adenocarcinoma of Lung 10/2019
1	Hypopituitarism (Sheehan's Syndrome) 10/2019
1	Headache (Headaches) 10/2019
1	Pituitary Apoplexy 10/2019
1	Hyperprolactinemia 10/2019
1	Ophthalmoplegia (External Ophthalmoplegia) 10/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2019
1	Lymphatic Metastasis 02/2019
1	Hypoparathyroidism 02/2017

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	6-methyladenineIBA 04/2022 - 01/2020
2	AntigensIBA 04/2022 - 02/2019
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2020
2	Long Noncoding RNAIBA 05/2021 - 01/2020
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 01/2014
2	Bromocriptine (Parlodel)FDA LinkGeneric 10/2019 - 01/2014
2	CarbonIBA 02/2017 - 10/2014
1	Messenger RNA (mRNA)IBA 04/2022
1	ParvalbuminsIBA 01/2022
1	Circular RNAIBA 01/2022
1	Competitive Endogenous RNAIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	MethyltransferasesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 12/2021
1	Cadherins (E-Cadherin)IBA 05/2021
1	VimentinIBA 05/2021
1	Biological ProductsIBA 05/2021
1	Blood Glucose (Blood Sugar)IBA 04/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 04/2021
1	ChemokinesIBA 01/2021
1	CytokinesIBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Cabergoline FDA LinkGeneric 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Lysine (L-Lysine)FDA Link 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	ProlactinIBA 10/2019
1	squamous cell carcinoma-related antigenIBA 02/2019
1	Protein Kinases (Protein Kinase)IBA 10/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2017
1	ParaffinIBA 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	Formaldehyde (Formol)FDA Link 10/2017
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Dopamine (Intropin)FDA LinkGeneric 01/2014
1	Protein Isoforms (Isoforms)IBA 01/2014
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2014

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021
1	Thyroidectomy 02/2017